Comments
Life Insurance Corporation of India (LIC) has diluted its stake in GlaxoSmithKline Pharmaceuticals from 6.402 per cent to 4.357 per cent. In a disclosure to the stock exchanges, LIC said that it has sold about 34.20 lakh shares or 2.045 per cent of its holding in the global pharma major during September 2018-22 period.
The stake sale happened at an average price of ₹1,549.40, LIC said. Shares of insurance major on Wednesday closed one per cent lower at ₹663.20, while those of Glaxo slid 0.55 per cent at ₹1,409.90.
Besides LIC, General Insurance Corporation of India, too, holds 1.42 per cent stake in GlaxoSmithKline Pharma, according to June-end shareholding pattern available with the exchanges.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.